- Tytuł:
- Safety and efficacy of trastuzumab biosimilar plus irinotecan or gemcitabine in patients with previously treated HER2 (ERBB2)-positive non-breast/non-gastric solid tumors: a phase II basket trial with circulating tumor DNA analysis
- Autorzy:
- Źródło:
- In ESMO Open June 2023 8(3)
Czasopismo naukowe